Display options
Share it on

Emerg Microbes Infect. 2012 Nov;1(11):e39. doi: 10.1038/emi.2012.37. Epub 2012 Nov 07.

Identification and characterization of a novel incompatibility group X3 plasmid carrying bla NDM-1 in Enterobacteriaceae isolates with epidemiological links to multiple geographical areas in China.

Emerging microbes & infections

Pak-Leung Ho, Zhen Li, Wai-U Lo, Yuk-Yam Cheung, Chi-Ho Lin, Pak-Chung Sham, Vincent Chi Chung Cheng, Tak-Keung Ng, Tak-Lun Que, Kin-Hung Chow

Affiliations

  1. Department of Microbiology, The University of Hong Kong , Hong Kong, China ; Carol Yu Center for Infection, The University of Hong Kong , Hong Kong, China.
  2. Department of Microbiology, The University of Hong Kong , Hong Kong, China.
  3. Centre for Genomic Sciences, The University of Hong Kong , Hong Kong, China.
  4. Department of Microbiology, Queen Mary Hospital, Hospital Authority , Hong Kong, China.
  5. Department of Clinical Pathology, Princess Margaret Hospital, Hospital Authority , Hong Kong, China.
  6. Department of Clinical Pathology, Tuen Mun Hospital, Hospital Authority , Hong Kong, China.

PMID: 26038408 PMCID: PMC3630922 DOI: 10.1038/emi.2012.37

Abstract

The New Delhi metallo-β-lactamase (NDM-1) is one of the most important resistance traits in Enterobacteriaceae. We characterized nine bla NDM-1 producing Enterobacteriaceae recovered from seven patients who have recently travelled or been treated in India (n=1) or mainland China (n=6) during December 2010-May 2012. All the China-linked patients had no links to the Indian subcontinent. The bla NDM-1 carrying plasmids belonged to the novel IncX3 (∼50 kb, in seven isolates including two Escherichia coli, two Klebsiella pneumoniae, one Citrobacter freundii, one Enterobacter aerogenes and one E. cloacae), IncA/C2 (∼140 kb, in one E. coli) or FII-F1B groups (∼110 kb, in one E. coli). Restriction fragment length polymorphism analysis of the seven IncX3 plasmids revealed identical pattern in six and two bands difference in the remaining one. The IncX3 plasmids carrying bla NDM-1 were epidemiologically linked to Guangzhou (n=1), Hunan (n=4), Haifeng (n=1) and Dongguan (n=1) in mainland China. Complete sequencing of the IncX3 plasmid pNDM-HN380 revealed that it was 54 035 bp long and encoded 52 open reading frames. The bla NDM-1 gene was found in a transposon-like structure flanked by ISAba125 and IS26, inserted into the plasmid genetic load region. The sequences of the bla NDM-1 containing module within the two IS elements were identical to those previously described for bla NDM-1-positive Tn125 in the plasmids or chromosome of Acinetobacter isolates. In summary, this is the first description of IncX3 plasmids carrying bla NDM-1. The findings indicate the worrisome involvement of an epidemic plasmid in the dissemination of NDM-1 in China.

Keywords: NDM-1; antimicrobial resistance; carbapenemases; epidemiology; incompatibility groups; plasmids

References

  1. Int J Antimicrob Agents. 2010 Sep;36(3):205-10 - PubMed
  2. Science. 2007 Jan 12;315(5809):251-2 - PubMed
  3. Antimicrob Agents Chemother. 2008 Jul;52(7):2680-2 - PubMed
  4. J Antimicrob Chemother. 2012 Jul;67(7):1645-50 - PubMed
  5. J Microbiol Methods. 2005 Dec;63(3):219-28 - PubMed
  6. PLoS One. 2011 Mar 21;6(3):e17989 - PubMed
  7. Plasmid. 2012 Jul;68(1):43-50 - PubMed
  8. Int J Antimicrob Agents. 2010 Nov;36 Suppl 3:S8-14 - PubMed
  9. Protein Cell. 2011 Mar;2(3):250-8 - PubMed
  10. Antimicrob Agents Chemother. 2011 Jun;55(6):3036-8 - PubMed
  11. Antimicrob Agents Chemother. 1983 Aug;24(2):201-8 - PubMed
  12. Lancet Infect Dis. 2011 May;11(5):355-62 - PubMed
  13. PLoS One. 2011;6(9):e25334 - PubMed
  14. Clin Microbiol Infect. 2012 May;18(5):E128-30 - PubMed
  15. Nat Rev Microbiol. 2007 Feb;5(2):157-61 - PubMed
  16. J Clin Microbiol. 2012 Apr;50(4):1433-6 - PubMed
  17. Plasmid. 2008 Jul;60(1):59-74 - PubMed
  18. Antimicrob Agents Chemother. 2012 Apr;56(4):1698-702 - PubMed
  19. Antimicrob Agents Chemother. 2012 May;56(5):2790-1 - PubMed
  20. Antimicrob Agents Chemother. 2012 May;56(5):2784-5 - PubMed
  21. Emerg Infect Dis. 2012 Mar;18(3):532-4 - PubMed
  22. BMC Genomics. 2008 Feb 08;9:75 - PubMed
  23. Eur J Clin Microbiol Infect Dis. 2010 Dec;29(12):1501-6 - PubMed
  24. Antimicrob Agents Chemother. 2012 Apr;56(4):1673-9 - PubMed
  25. Bioinformatics. 2009 Aug 15;25(16):2071-3 - PubMed
  26. J Antimicrob Chemother. 2011 Aug;66(8):1730-3 - PubMed
  27. Antimicrob Agents Chemother. 2012 Feb;56(2):783-6 - PubMed
  28. Lancet Infect Dis. 2010 Sep;10 (9):597-602 - PubMed
  29. Appl Environ Microbiol. 2002 Aug;68(8):3780-9 - PubMed
  30. Trends Microbiol. 2011 Dec;19(12):588-95 - PubMed
  31. Mol Microbiol. 2006 Jun;60(5):1136-51 - PubMed
  32. Antimicrob Agents Chemother. 2011 Sep;55(9):4224-9 - PubMed
  33. Antimicrob Agents Chemother. 2009 Dec;53(12):5046-54 - PubMed
  34. J Antimicrob Chemother. 2012 Nov;67(11):2661-4 - PubMed
  35. PLoS One. 2012;7(5):e37152 - PubMed
  36. J Mol Biol. 2000 Oct 27;303(3):371-82 - PubMed
  37. Antimicrob Agents Chemother. 2010 Sep;54(9):3564-8 - PubMed
  38. J Clin Microbiol. 2005 Aug;43(8):4178-82 - PubMed
  39. PLoS One. 2012;7(4):e34752 - PubMed
  40. J Antimicrob Chemother. 2012 Jun;67(6):1553-5 - PubMed
  41. J Antimicrob Chemother. 2010 Dec;65(12):2518-29 - PubMed
  42. J Antimicrob Chemother. 2012 Sep;67(9):2114-22 - PubMed
  43. Antimicrob Agents Chemother. 2004 Jan;48(1):15-22 - PubMed
  44. Antimicrob Agents Chemother. 2012 Feb;56(2):1087-9 - PubMed

Publication Types